medlive.cn

What medlive.cn does

medlive.cn (医脉通), operated by Beijing Medlive Interchange Technology Co., Ltd. and publicly listed on HKEX (ticker 2192), is a Chinese medical information and clinical decision support platform serving practicing physicians, specialists, and pharmaceutical companies across 28+ medical departments including cardiology, oncology, neurology, hepatology, and hematology. The platform aggregates clinical guidelines, disease knowledge bases, drug references, medical literature search, conference coverage, and case-based learning content, distributed through a main website, native mobile apps, WeChat mini-programs, and dedicated department-specific sub-sites. Its core technology stack includes MedSeeker (an NLP-based clinical Q&A tool), a GPT-based medical assistant, and MedPaper for AI-assisted manuscript writing, all grounded in the platform's proprietary clinical content corpus.

The business operates a dual-sided model. On the supply side, Medlive monetizes a large base of Chinese physicians through pharma marketing services — branded messaging channels (e信使/eMessenger), educational broadcasts (e脉播/eBroadcast), sponsored content, and enterprise columns for global pharma (Eli Lilly, GSK, Bayer, Sanofi, Novo Nordisk, Merck) and domestic leaders (Hengrui, Tasly). On the demand side, individual physicians access most content for free and pay for VIP subscriptions, premium CME courses (¥199-¥499), and tools such as clinical calculators and literature management software. Additional revenue streams include clinical trial technology (EDC, DCT, Digital Intelligence Platform), research services (omics analysis, translation, journal selection), career services, and recruitment. The company was founded in 2005 in Beijing and holds regulatory certifications including Internet Drug and Medical Device Information Service filing and Publication Business License.

Name

medlive.cn

Legal name

北京医脉互通科技有限公司

Website

https://medlive.cn

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

251–500 employees

Short description

medlive.cn (医脉通) is a Chinese medical information and clinical decision support platform serving practicing physicians across 28+ specialties, monetizing via pharma marketing channels, subscriptions, CME courses, and clinical trial technology.

Ownership category

akta.pro rank

Product category

Healthcare Professional Platform

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYEDAGAGAA

Medical & Clinical Reference (Physicians, Nursing, Allied Health)

Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing

SECONDARYEDAAALAC

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)

Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)

SECONDARYEDAGANAJ

Healthcare & Clinical Professional Development (CME/CE)

Education/Educational Publishing & Learning Content/Professional Development & Training Materials

Keywords

• Clinical decision support
• Medical education platform
• Physician engagement tools
• Pharmaceutical marketing services
• Medical knowledge database

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical Company Marketing Services: Medlive provides pharmaceutical companies with marketing channels to reach medical professionals through brand messaging platforms (品牌信使), enterprise columns (企业专栏), and targeted medical communications. Companies like GlaxoSmithKline, Eli Lilly, and Hengrui Medicine maintain presence on the platform.
2. VIP Subscription Services: The platform offers VIP subscriptions for advanced features including premium clinical guidelines, exclusive educational content, and discount coupons for medical resources. Users earn '麦粒' (Maili points) through daily check-ins that can be redeemed for premium services.
3. Medical Education and Conference Services: The platform organizes and broadcasts medical conferences and provides premium educational courses, some available for paid enrollment. Courses like '心力衰竭规范化诊疗系列讲座' are priced at ¥399 with discounts to ¥199.
4. Medical Software and Tools: The platform distributes various medical software tools including literature management (医学文献王), medical dictionaries, clinical calculators, and specialized medical applications through its software center.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Medlive.cn operates a medical professional platform serving Chinese physicians with clinical decision support tools including the MedSeeker AI system, comprehensive clinical guidelines database, drug reference tools, and disease knowledge bases spanning 28+ medical specialties. The platform also provides pharmaceutical companies with branded marketing channels to reach physicians, and offers continuing medical education through webinars, conferences, and case-based learning content.

Product overview

Medlive.cn (医脉通) is a comprehensive medical professional platform offering an integrated ecosystem of clinical decision support tools and services. The platform architecture consists of a core clinical knowledge base (临床知识库) supplemented by specialized modules including MedSeeker AI for intelligent clinical decision support, the Clinical Guidelines database (临床指南), Drug Reference (用药参考), and Disease Knowledge Base (疾病知识库). Additional modules span research services (e研通, MedPaper), education (e学院, 知识银行, e脉播), clinical trial technology (EDC, DCT, 数智化平台), communication (e信使), literature retrieval (医学文献王), and specialty content across 30+ medical departments including Cardiology, Oncology, Neurology, and Hepatology. The platform also includes consumer-facing mobile applications and AI-powered tools like GPT for medical inquiries.

Differentiator

Problem solved

Functional benefit

Brands

• MedSeeker: AI-powered clinical decision support tool
• e信使 (eMessenger)
• e脉播 (eBroadcast)
• e研通 (eYanTong)
• 知识银行 (Knowledge Bank)
• 用药参考 (Drug Reference)
• 临床指南 (Clinical Guidelines)

Products and services

• MedSeeker
• Clinical Guidelines (临床指南)
• Drug Reference (用药参考)
• Disease Knowledge Base (疾病知识库)
• eMessenger (e信使)
• eBroadcast (e脉播)
• eResearch (e研通)
• Knowledge Bank (知识银行)
• Medical Literature King (医学文献王)
• EDC (Electronic Data Capture)
• DCT (Decentralized Clinical Trials)
• Medlive Mobile App (医脉通APP)
• GPT Medical AI Assistant
• MedPaper
• eAcademy (e学院)
• Medical Conferences (医学会议)
• Medical Dictionary (医学大词典)
• Clinical Cases (临床病例)
• Medical Visualization (医脉可视)
• Medical Translation (医心医译)
• Medlive Career (医脉人才)
• Calculation Formulas (计算公式)
• Journal Selection & Submission (选刊投稿)

Quantifiable outcome

• MedSeeker AI provides evidence-based clinical recommendations with citations from authoritative medical sources

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

• Memorial Sloan Kettering Cancer CentercoreStrategic or Co-development Partner · 21 January 2026Medlive appointed Dr. Ghassan Abou-Alfa, a specialist from Memorial Sloan Kettering Cancer Center, to its Advisory Board to strengthen educational programming in hepatobiliary cancers, bringing clinical and research expertise from this leading US cancer center.
• Sarah Cannon Research InstitutecoreStrategic or Co-development Partner · 21 January 2026Medlive appointed Dr. Hans Lee from Sarah Cannon Research Institute to its Advisory Board to enhance educational content in multiple myeloma, leveraging expertise from this prominent US research institute focused on cancer therapeutics.
• UCLA (University of California, Los Angeles)coreStrategic or Co-development Partner · 21 January 2026Medlive appointed Dr. Aaron Lisberg from UCLA to its Advisory Board to strengthen thoracic oncology educational programming, bringing academic medical center expertise to the platform.
• GlaxoSmithKline China (葛兰素史克(中国)投资有限公司)majorGTM or Marketing PartnerGlaxoSmithKline maintains a branded messaging channel (哮喘云学院) on Medlive's e信使 platform with 69,262 followers, providing asthma education content to Chinese physicians.
• Eli Lilly (礼来)majorGTM or Marketing PartnerEli Lilly operates 达摩院 messaging channel on Medlive with 204,278 followers and 107,375 total reads, providing medical information related to their oncology and diabetes products.
• Jiangsu Hengrui Medicine (江苏恒瑞医药股份有限公司)majorGTM or Marketing PartnerHengrui Medicine maintains 瑞达学苑 brand messaging channel on Medlive for physician education and medical communications.
• Bayer Healthcare China (拜耳医药保健有限公司)majorGTM or Marketing PartnerBayer operates multiple brand messaging channels on Medlive including拜阿司匹灵, 拜瑞妥, and 拜小妥 with combined reach of over 760,000 interactions for cardiovascular and anticoagulation products.
• Novo Nordisk China (诺和诺德(中国)制药有限公司)majorGTM or Marketing PartnerNovo Nordisk maintains medical communications channels on Medlive for diabetes and cardiovascular products, including 灵丹 channel and 医线心泰 platform.
• Sanofi China (赛诺菲)majorGTM or Marketing PartnerSanofi operates multiple channels on Medlive including 基层医疗 and IH (International Health) divisions, reaching hundreds of thousands of physicians with cardiovascular and specialty medicine content.
• Tasly Pharmaceutical Group (天士力医药集团股份有限公司)minorGTM or Marketing PartnerTasly maintains 芪小参 brand messaging presence on Medlive for traditional Chinese medicine and cardiovascular product communications.
• Merck China (默克(中国))majorGTM or Marketing PartnerMerck operates 康忻 (cardiovascular) and 怡可安 (diabetes) brand messaging channels on Medlive reaching over 60,000 physicians.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about medlive.cn